A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation
Clinical trial NCT06441084 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06441084
- Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-30
- Primary completion
- 2028-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.